| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Lantheus Alpha Therapy, LLC serves as a 10% Owner at LNTH and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 5 sells. Those positions are worth an estimated $146.4M at current prices.
The biggest single holding is LNTH (~$110.9M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 60,431,039 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | CATX Perspective Therapeutics, Inc. | 10% Owner | Sell | 247,932 | $3.13 | $776,947.17 | -2.2% | - | - | |
| Sep 2, 2026 | CATX Perspective Therapeutics, Inc. | 10% Owner | Sell | 42,129 | $3.11 | $131,219.20 | -0.4% | - | - | |
| Sep 1, 2026 | CATX Perspective Therapeutics, Inc. | 10% Owner | Sell | 113,914 | $3.14 | $357,183.98 | -1.0% | - | - | |
| Mar 6, 2024 | LNTH Lantheus Holdings, Inc. | 10% Owner | Buy10b5-1 | 60,431,039 | $0.95 | $57,409,487.05 | +107.3% | +31.5% | +61.7% |